3 assets in Ataxia Telangiectasia

Therapeutic assets addressing Ataxia Telangiectasia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
N-Acetyl-L-Leucine Ataxia Telangiectasia	IntraBio Inc	P3	B (60)
Exemestane Ataxia Telangiectasia	Dana-Farber Cancer Institute	P2	CCC (53)
Tamoxifen Ataxia Telangiectasia	Dana-Farber Cancer Institute	P2	CCC (53)